Effects of Aerobic Training on Exercise Capacity in Patients With Advanced Cirrhosis 2
NCT ID: NCT01960127
Last Updated: 2022-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2013-10-15
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Aerobic Training on Exercise Capacity in Patients With Cirrhosis
NCT01799785
Effects of Home Based Exercise Therapy in Early Cirrhosis
NCT02267421
The Efficacy of Aerobic Exercise Training on Autonomic Nervous System and Endothelial Function in Patients with Compensated Cirrhosis
NCT06288828
Mechanisms Involved in the Benefits of an Exercise Programme in Patients With Cirrhosis
NCT01447537
The Role of Resistance Training in Non Alcoholic Fatty Liver Disease
NCT01264198
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aerobic Exercise
Supervised aerobic training 3 times per week for 8 weeks (30-60 minute sessions)
Aerobic Exercise
Aerobic exercise
Usual Care Group
These patients will continue with their normal daily activity ad will not be provided with supervised aerobic exercise training during the study period.
No Intervention
No Intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aerobic Exercise
Aerobic exercise
No Intervention
No Intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cirrhosis
* Child Pugh class B or C
* If required, primary or secondary variceal prophylaxis in place
Exclusion Criteria
* Hepatocelluar carcinoma beyond transplant criteria
* Active non-hepatocelluar carcinoma malignancy
* Significant cardiac disease
* Hemoglobin (\<80 g/L)
* Oxygen saturation at rest \<95%
* Known myopathy
* Chronic renal failure on dialysis
* Physical impairment making it impossible to ride an exercise bike or treadmill
* Orthopedic abnormality preventing exercise training
* HIV infection
* Patient unwilling to consent to study
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alberta
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Haykowsky, PhD
Role: STUDY_DIRECTOR
University of Alberta
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alberta, Mazankowski Heart Institute
Edmonton, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LZPTMH2.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.